Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
179.4 GBX | +0.79% | +2.05% | +10.67% |
May. 10 | StanChart exec sells shares; new Alphawave CFO buys | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 4.81B 6.13B | Sales 2025 * | 4.99B 6.35B | Capitalization | 1.9B 2.42B |
---|---|---|---|---|---|
Net income 2024 * | 152M 194M | Net income 2025 * | 163M 208M | EV / Sales 2024 * | 0.52 x |
Net Debt 2024 * | 618M 786M | Net Debt 2025 * | 505M 643M | EV / Sales 2025 * | 0.48 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.4
x | Employees | 50,000 |
Yield 2024 * |
2.24% | Yield 2025 * |
2.59% | Free-Float | 98.05% |
Latest transcript on Serco Group plc
1 day | +0.96% | ||
1 week | -2.25% | ||
1 month | -2.36% | ||
3 months | -5.92% | ||
6 months | +12.52% | ||
Current year | +9.81% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Nigel Crossley
DFI | Director of Finance/CFO | 61 | 13-12-31 |
Paul Checketts
IRC | Investor Relations Contact | - | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Lynne Peacock
BRD | Director/Board Member | 70 | 17-06-30 |
John Rishton
CHM | Chairman | 66 | 16-09-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 179.4 | +0.79% | 1 659 334 |
24-05-31 | 178 | +0.96% | 5,041,104 |
24-05-30 | 176.3 | +0.34% | 1,973,579 |
24-05-29 | 175.7 | -0.06% | 2,764,574 |
24-05-28 | 175.8 | -3.46% | 2,347,092 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.81% | 2.42B | |
+12.50% | 68.79B | |
+7.35% | 17.45B | |
+20.68% | 13.58B | |
+8.66% | 13.35B | |
+12.48% | 9.8B | |
-20.94% | 6.74B | |
-4.74% | 5.95B | |
+2.67% | 5.23B | |
-3.21% | 4.85B |
- Stock Market
- Equities
- SRP Stock